Search

everythinglearnresearchcommunity

for

Search:↓

New indole-based compounds, particularly cemtirestat, show promise as dual-function drugs for diabetic complications.

A new compound, 3a, effectively fights prostate cancer better than finasteride.

Deucravacitinib did not significantly improve hair regrowth in alopecia areata patients.

Thyrotropin-releasing hormone may help control skin and hair growth and could aid in treating related disorders.

New treatments targeting androgen receptors show promise for drug-resistant prostate cancer.

CTP-543 is generally safe for treating alopecia areata.

ARQ-234, a protein designed to treat atopic dermatitis, shows increased effectiveness in early testing.

CRH promotes fat production in skin cells, affecting conditions like acne.

Cinacalcet may help treat hereditary vitamin D resistant rickets safely.

Dyclonine can effectively reduce skin issues by inhibiting the TRPV3 channel.

MR antagonists may improve skin health and wound healing, especially in aging.

TRPA1 and TRPV1 channels don't affect mechanotransduction in rat sinus hair follicles.

Blocking CRF-R1 can reduce alcohol intake in stressed mice.

Horizant has risks like other seizure drugs, Johnson & Johnson misled about Risperdal, and Quanterix found a possible link between brain oxygen loss and Alzheimer's markers.

Metyrapone effectively stabilizes severe Cushing's disease symptoms before surgery.

Two new compounds can block androgen receptor activity in different ways and may lead to new treatments for androgen-related diseases.

CRH can cause hair loss by promoting cell death in hair growth cells.

New steroid derivatives show promise as anticancer agents, even against resistant cells.

The nature of the side chain in RU 58841 derivatives greatly affects its AR affinity, with the N-(iodopropenyl) derivative 13 showing the highest AR binding affinity, suggesting its potential for developing high-affinity radioiodinated AR radioligands.

Finasteride blocks deoxycorticosterone's anticonvulsant effects in infant rats, but indomethacin doesn't.

Blocking certain brain processes reduces mating behavior in female rats.

A 50 mg non-loading dose of ritlecitinib is safe for adults and adolescents.

Dracorhodin perchlorate helps heal wounds in diabetic rats by reducing inflammation.

CRH causes hair loss by reducing cell survival in hair follicles.

RU58841, a substance from France, can potentially block the effects of hormones that cause hair loss and excessive hair growth, performing better than a similar substance, cyproterone acetate.

Block and replace therapy improved symptoms in recurrent cyclic Cushing’s disease.

Targeting NETs may help reduce fibrosis in Crohn's disease.

Prasugrel is better than clopidogrel at preventing heart damage and improving blood flow in small heart vessels during heart artery procedures.

Clascoterone may be an effective topical treatment for hair loss.

CRH causes hair loss by reducing autophagy and increasing cell death in hair cells.